Trial Profile
Study of the Practice of Debiri in France: Indications, Associations to Systemic Treatments, Efficiency, Tolerance - Prospective Practice Survey
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2022
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 18 Aug 2022 Planned End Date changed from 3 Apr 2022 to 15 Oct 2022.
- 18 Aug 2022 Planned primary completion date changed from 3 Apr 2022 to 15 Oct 2022.
- 23 Mar 2022 Planned End Date changed from 3 Feb 2022 to 3 Apr 2022.